Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 38 249.5 |
96 | EP file number | EAKZ | 03 70 3804.9 |
86 | WO file number | WAKZ | PCT/US03/01109 |
97 | EP publication number | EPN | 1523325 |
87 | WO publication number | WPN | 2003061362 |
54 | Designation/title | TI | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG DES POLYZYSTISCHEN OVARIALSYNDROMS |
51 | IPC main class | ICM (ICMV) | A61K 38/22 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/26 (2006.01), C07K 14/575 (2006.01), C07K 14/605 (2006.01), A61P 5/24 (2006.01), A61P 15/00 (2006.01) |
22 | DE application date | DAT | Jan 14, 2003 |
96 | EP application date | EAT | Jan 14, 2003 |
86 | WO application date | WAT | Jan 14, 2003 |
43 | Date of first publication | OT | Jul 31, 2003 |
| Date of publication of grant | PET | Aug 31, 2011 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
72 | Inventor | IN | HATHAWAY, David, R., Lincoln, NE 78524, US |
74 | Representative | VTR | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
| Address for service | | Lorenz Seidler Gossel Rechtsanwälte Patentanwälte Partnerschaft mbB, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 317126 Dec 11, 2002
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 350395 P Jan 22, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document: EP000001523325 Searchable text:
EP000001523325 Original document:
EP000001523325B1 Searchable text:
EP000001523325B1 Original document:
WO002003061362 Searchable text:
WO002003061362 |
43 | Date of first publication | EVT | Jul 31, 2003 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2022 (Show all update days)(Hide all update days)- Jan 5, 2022; Oct 29, 2018; Nov 16, 2017; Nov 24, 2016; Sep 20, 2016; Feb 10, 2016; Oct 26, 2015; Jan 23, 2015; Feb 8, 2014; Jan 28, 2014; Sep 24, 2013; Aug 1, 2013; Jun 11, 2013; Jun 4, 2013; Mar 1, 2013; Feb 8, 2013; Jan 27, 2013; Sep 27, 2012; Mar 1, 2012; Feb 7, 2012; Nov 10, 2011; Oct 28, 2011; Sep 24, 2011; Sep 22, 2011; Sep 20, 2011; Sep 7, 2011; Sep 1, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 11)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 10, 2013 |
| Issue number | HN | 31 |
| Year | PJ | 2013 |
| Publication date | VT | Aug 1, 2013 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 2 |
71/73 | Applicant/owner | INH | Amylin Pharmaceuticals, LLC, San Diego, Calif., US; AstraZeneca Pharmaceuticals LP, 19803 Wilmington, Del., US |
71/73 | Previous applicant/owner | INHF | Amylin Pharmaceuticals, LLC, San Diego, Calif., US |